The Genetic and Epigenetic Basis of Neurodevelopmental Disorders

A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Human Genomics and Genetic Diseases".

Deadline for manuscript submissions: 20 December 2024 | Viewed by 112

Special Issue Editor


E-Mail Website
Guest Editor
Department of Genetics, University of Pennsylvania, Philadelphia, PA, USA
Interests: neuroepigenetics in brain development and disease

Special Issue Information

Dear Colleagues,

Next-generation sequencing technologies have revolutionized gene discovery for a variety of medical conditions, including a group of disorders affecting brain development and function known as neurodevelopmental disorders (NDDs). Despite the common phenotypic heterogeneity present in NDDs, the identification of genetic causes has significantly improved the assessment of recurrent risks and the foreseeing of future medical complications, which has important ramifications for genetic counseling and patient management. Modeling the genetic causes of NDDs in mice and other model organisms has also enhanced the understanding of disease pathophysiology and uncovered new strategies for therapeutic development. To date, hundreds of genes and genomic regions have been implicated in NDDs. Notably, many of these genes are involved in the regulation of DNA methylation, histone modifications, non-coding RNAs, and three-dimensional chromatin organization. The involvement of these fundamental epigenetic processes has not only opened new avenues but also stimulated a community effort to investigate the pathophysiology underlying NDDs through the lens of neuroepigenetics.

In this Special Issue, we solicit original studies and review articles that focus on the genetic and epigenetic basis of NDDs with the aim of better understanding the interplay between genetics, epigenetics, and neurodevelopment. The goal is to reveal new insights into the underlying pathogenic mechanisms and pave the way for potential therapeutic interventions that target and modulate the epigenetic processes to mitigate or reverse clinical symptoms in NDDs.

Prof. Dr. Zhaolan (Joe) Zhou
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neurodevelopmental disorders
  • neural development
  • epigenetics
  • DNA methylation
  • histone methylation
  • histone acetylation
  • non-coding RNAs
  • chromatin organization
  • therapeutics

Published Papers

This special issue is now open for submission.
Back to TopTop